BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24734315)

  • 1. Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan.
    Sakamoto S; Kasahara M; Mizuta K; Kuroda T; Yagi T; Taguchi T; Inomata Y; Umeshita K; Uemoto S;
    Liver Transpl; 2014 Mar; 20(3):333-46. PubMed ID: 24734315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living and deceased donor liver transplantation for unresectable hepatoblastoma at a single center.
    Mejia A; Langnas AN; Shaw BW; Torres C; Sudan DL
    Clin Transplant; 2005 Dec; 19(6):721-5. PubMed ID: 16313316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
    Isono K; Ohya Y; Lee KJ; Hashimoto S; Kadohisa M; Sakisaka M; Uto K; Hayashida S; Yamamoto H; Yamamoto H; Sugawara Y; Inomata Y
    Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation.
    Kanazawa H; Fukuda A; Mali VP; Rahayatri TH; Hirata Y; Sasaki K; Uchida H; Shigeta T; Sakamoto S; Matsumoto K; Kasahara M
    Pediatr Transplant; 2016 May; 20(3):401-7. PubMed ID: 27012966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric liver transplantation for hepatoblastoma: a single center experience.
    Kim T; Kim DY; Kim KM; Seo JJ; Park KM; Lee YJ; Lee SG
    Transplant Proc; 2012 Mar; 44(2):523-5. PubMed ID: 22410061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living-donor liver transplantation for hepatoblastoma.
    Kasahara M; Ueda M; Haga H; Hiramatsu H; Kobayashi M; Adachi S; Sakamoto S; Oike F; Egawa H; Takada Y; Tanaka K
    Am J Transplant; 2005 Sep; 5(9):2229-35. PubMed ID: 16095502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
    Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent Outcome Following Liver Transplantation for Hepatoblastoma Using an Extensive En Bloc Hepatectomy Technique.
    Herden U; Grabhorn E; Lenhartz H; Kütemeier R; Fischer L
    Transplant Proc; 2019; 51(6):1887-1891. PubMed ID: 31262438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of early inflow exclusion during living donor liver transplantation for unresectable hepatoblastoma.
    Uchida H; Fukuda A; Sasaki K; Hirata Y; Shigeta T; Kanazawa H; Nakazawa A; Miyazaki O; Nosaka S; Mali VP; Sakamoto S; Kasahara M
    J Pediatr Surg; 2016 Nov; 51(11):1807-1811. PubMed ID: 27325360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Surgical Resection and Chemotherapy for Unresectable Hepatoblastoma With Pulmonary Metastases and for Lung Recurrence After Liver Transplantation: A Case Report.
    Takase K; Ueno T; Yamamichi T; Iwasaki S; Toyama C; Okada Y; Nomura M; Watanabe M; Sawada A; Miyamura T; Bessho K; Inoue M; Usui N; Okuyama H
    Transplant Proc; 2022 Mar; 54(2):556-559. PubMed ID: 35074164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
    Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
    J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
    Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of donor graft type on survival after liver transplantation for hepatoblastoma in children.
    Ziogas IA; Schmoke N; Yoeli D; Cullen JM; Boster JM; Wachs ME; Adams MA
    Pediatr Transplant; 2024 Feb; 28(1):e14641. PubMed ID: 37946593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors for Liver Transplantation in Unresectable Hepatoblastoma.
    Triana Junco P; Cano EM; Dore M; Jimenez Gomez J; Sánchez Galán A; Vilanova-Sánchez A; Andres A; Encinas JL; Martinez L; Hernandez F; Lopez Santamaria M
    Eur J Pediatr Surg; 2019 Feb; 29(1):28-32. PubMed ID: 30086577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma after liver transplantation: A single-institute experience.
    Umeda K; Okajima H; Kawaguchi K; Nodomi S; Saida S; Kato I; Hiramatsu H; Ogawa E; Yoshizawa A; Okamoto S; Uemoto S; Watanabe K; Adachi S
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29341393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for the management of hepatoblastoma.
    Cillo U; Ciarleglio FA; Bassanello M; Brolese A; Vitale A; Boccagni P; Zanus G; Zancan L; D'Antiga L; Dall'igna P; Montin U; Gringeri E; Carraro A; Cappuzzo G; Violi P; Baldessin M; Bridda A; D'Amico DF; Perilongo G
    Transplant Proc; 2003 Dec; 35(8):2983-5. PubMed ID: 14697956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.